Related Experiment Video
Updated: Jan 30, 2026

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
Published on: May 5, 2023
Epigenetic mechanism and target therapy of UHRF1 protein complex in malignancies
Busheng Xue1, Jiansong Zhao1, Penghui Feng2
1Department of Spine and Joint Surgery, Shengjing Hospital, China Medical University, Shenyang, People's Republic of China, liy15@sj-hospital.org.
Abstract:
Ubiquitin-like with plant homeodomain and really interesting new gene finger domains 1 (UHRF1) functions as an epigenetic regulator recruiting PCNA, DNMT1, histone deacetylase 1, G9a, SuV39H, herpes virus-associated ubiquitin-specific protease, and Tat-interactive protein by multiple corresponding domains of DNA and H3 to maintain DNA methylation and histone modifications. Overexpression of UHRF1 has been found as a potential biomarker in various cancers resulting in either DNA hypermethylation or global DNA hypo-methylation, which participates in the occurrence, progression, and invasion of cancer. The role of UHRF1 in the reciprocal interaction between DNA methylation and histone modifications, the dynamic structural transformation of UHRF1 protein within epigenetic code replication machinery in epigenetic regulations, as well as modifications during cell cycle and chemotherapy targeting UHRF1 are evaluated in this study.
Insights
Ubiquitin-like with plant homeodomain and really interesting new gene finger domains 1 (UHRF1) is an epigenetic regulator crucial for DNA methylation and histone modifications. Its overexpression is a cancer biomarker, impacting disease progression and response to chemotherapy.
Area of Science:
- Epigenetics
- Molecular Biology
- Cancer Research
Background:
- Ubiquitin-like with plant homeodomain and really interesting new gene finger domains 1 (UHRF1) is a key epigenetic regulator.
- UHRF1 maintains DNA methylation and histone modifications by recruiting various proteins.
- UHRF1 overexpression is implicated in cancer development, progression, and invasion.
Purpose of the Study:
- To evaluate the role of UHRF1 in the interplay between DNA methylation and histone modifications.
- To analyze the dynamic structural transformations of UHRF1 in epigenetic regulation.
- To investigate UHRF1 modifications during the cell cycle and its potential as a chemotherapy target.
Main Methods:
- Literature review and analysis of UHRF1's molecular functions.
- Examination of UHRF1's role in epigenetic code replication.
- Assessment of UHRF1's involvement in cancer biology and therapeutic strategies.
Main Results:
- UHRF1's recruitment of specific proteins is essential for epigenetic maintenance.
- Aberrant UHRF1 expression correlates with altered DNA methylation patterns in cancer.
- UHRF1's structural dynamics are critical for its function in epigenetic regulation.
Conclusions:
- UHRF1 plays a significant role in maintaining epigenetic homeostasis and is dysregulated in cancer.
- Understanding UHRF1's structural dynamics and cell cycle modifications can lead to novel therapeutic approaches.
- Targeting UHRF1 presents a promising strategy for cancer treatment.
More Related Videos
09:56Epigenetic Engineering of K562 Cells: Dual-Vector Episomal Strategy for Stable Targeted DNA Methylation using dCas9-DNMT3A and -HDAC1 Fusion Proteins
Published on: October 31, 2025
08:34Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
Published on: February 6, 2019
Related Concept Videos
Epigenetic Regulation
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Protein Complexes with Interchangeable Parts
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Protein Complex Assembly
Targeted Cancer Therapies
There are several types of targeted therapies against...